A temporal and spatial summation model for T-cell activation: Signal integration and antigen decoding

Trends in Immunology

Volumn 23, Issue 12, 2002, Pages 592-595

  Rachmilewitz, Jacob ^a   Lanzavecchia, Antonio ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; CELL ACTIVATION; CELL KINETICS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISSOCIATION CONSTANT; HUMAN; NERVE CELL; RECEPTOR OCCUPANCY; REVIEW; SIGNAL TRANSDUCTION; SPATIAL SUMMATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TEMPORAL SUMMATION;

ANIMALS; AUTOANTIGENS; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0036898764     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)02342-6     Document Type: Review

References (40)

1. Sykulev Y., et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T-cell response. Immunity. 4:1996;565-571.
2. Harding C.V., Unanue E.R. Quantitation of antigen-presenting cell MHC class II-peptide complexes necessary for T-cell stimulation. Nature. 346:1990;574-576.
3. Demotz S., et al. The minimal number of class II MHC-antigen complexes needed for T-cell activation. Science. 249:1990;1028-1030.
4. Weiss A., et al. Ligand-receptor interactions required for commitment to the activation of the interleukin-2 gene. J. Immunol. 138:1987;2169-2176.
5. Valitutti S., et al. Sustained signaling leading to T-cell activation results from prolonged T-cell receptor occupancy. Role of T-cell actin cytoskeleton. J. Exp. Med. 181:1995;577-584.
6. Valitutti S., et al. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:1995;148-151.
7. Gunzer M., et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity. 13:2000;323-332.
8. Beeson C., et al. Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J. Exp. Med. 184:1996;777-782.
9. + CTL clones is determined by the frequency of serial TCR engagement. J. Immunol. 161:1998;553-562.
10. Muller S., et al. Kinetics and extent of protein tyrosine kinase activation in individual T cells upon antigenic stimulation. Immunology. 97:1999;287-293.
11. Alcover A., Alarcon B. Internalization and intracellular fate of TCR-CD3 complexes. Crit. Rev. Immunol. 20:2000;325-346.
12. Berne, R.M. and Levy, M.N. (eds) (1998) Synaptic transmission. In Physiology (4th Ed), pp. 43-59, Mosby Press.
13. Monks C.R., et al. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:1998;82-86.
14. Kalergis A.M., et al. Efficient T-cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2:2001;229-234.
15. Matsui K., et al. Kinetics of T-cell receptor binding to peptide-I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12862-12866.
16. Wulfing C., et al. Kinetics and extent of T-cell activation as measured with the calcium signal. J. Exp. Med. 185:1997;1815-1825.
17. 2+ signaling. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8471-8476.
18. Rosette C., et al. The impact of duration versus extent of TCR occupancy on T-cell activation: a revision of the kinetic proofreading model. Immunity. 15:2001;59-70.
19. Borovsky Z., et al. Serial triggering of T-cell receptors results in incremental accumulation of signaling intermediates. J. Biol. Chem. 277:2002;21529-21536.
20. Viola A., et al. T-lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:1999;680-682.
21. Wulfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T-cell activation. Science. 282:1998;2266-2269.
22. Bromley S.K., et al. The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2:2001;1159-1166.
23. Lanzavecchia A., Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat. Immunol. 2:2001;487-492.
24. Viola A., Lanzavecchia A. T-cell activation determined by T-cell receptor number and tunable thresholds. Science. 273:1996;104-106.
25. + T cells. J. Exp. Med. 186:1997;757-766.
26. Iezzi G., et al. The duration of antigenic stimulation determines the fate of naïve and effector T cells. Immunity. 8:1998;89-95.
27. Preckel T., et al. Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J. Exp. Med. 185:1997;1803-1813.
28. Lyons D.S., et al. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:1996;53-61.
29. Lanzavecchia A. Understanding the mechanisms of sustained signaling and T-cell activation. J. Exp. Med. 185:1997;1717-1719.
30. 2+ signals and immunosuppression. Nature. 383:1996;837-840.
31. 2+ response amplitude and duration. Nature. 386:1997;855-858.
32. Dolmetsch R.E., et al. Calcium oscillations increase the efficiency and specificity of gene expression. Nature. 392:1998;933-936.
33. 2+ oscillations. Science. 279:1998;227-230.
34. 2+ spike frequency can optimize gene expression. Nature. 392:1998;936-941.
35. Nicholson L.B., et al. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:1995;397-405.
36. Rogers P.R., et al. Modulation of naïve CD4 T-cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response. J. Immunol. 160:1998;3698-3704.
37. Rogers P.R., Croft M. Peptide dose, affinity and time of differentiation can contribute to the Th1/Th2 cytokine balance. J. Immunol. 163:1999;1205-1213.
38. Kessler B., et al. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production. J. Immunol. 161:1998;6939-6946.
39. Wulfing C., et al. Costimulation and endogenous MHC ligands contribute to T-cell recognition. Nat. Immunol. 3:2002;42-47.
40. Bakker T.R., van der Merwe P.A. Self-help in T-cell recognition? Nat. Immunol. 3:2002;11-12.